Sales Nexus CRM

New Research Reveals 62% of AFib Patients Unaware of Condition Before Diagnosis

By FisherVista

TL;DR

Early AFib detection by the American Heart Association offers a strategic health advantage, reducing stroke risk fivefold through proactive management and treatment.

AFib is managed through medication, procedures, and lifestyle changes like weight control and blood pressure management, based on personalized healthcare plans.

Raising AFib awareness and early treatment improves global health equity, preventing strokes and saving lives through community support and education.

AFib affects over 6 million Americans, often undiagnosed, with symptoms like irregular heartbeat and fatigue, but is treatable with proper care.

Found this article helpful?

Share it with your network and spread the knowledge!

New Research Reveals 62% of AFib Patients Unaware of Condition Before Diagnosis

New research from the American Heart Association reveals that 62% of atrial fibrillation patients had no prior knowledge of their condition before receiving a diagnosis, exposing significant gaps in public awareness about this serious heart rhythm disorder. The findings, based on a nationwide survey of 1,200 participants including 770 AFib patients and 430 caregivers conducted between January and March 2025, demonstrate the urgent need for increased public education about AFib symptoms and risk factors.

Atrial fibrillation affects over 6 million people in the U.S., with projections indicating this number will double by 2030 according to the latest statistics from the American Heart Association. The condition increases stroke risk by up to five times, making early detection and treatment critical for stroke prevention. Dr. José Joglar, professor of cardiac electrophysiology at UT Southwestern Medical Center and chair of the 2023 AFib guidelines, emphasized that "early detection and proactive management can make a life-saving difference" given the growing prevalence driven by high blood pressure, diabetes, obesity, and an aging population.

The research findings indicate that AFib patients reported experiencing an average of three symptoms before diagnosis, yet many failed to recognize these as warning signs. While irregular heartbeat is the most commonly recognized symptom, other indicators include shortness of breath, fatigue, dizziness, chest pain, or fainting. Risk factors include age, uncontrolled high blood pressure, Type 2 diabetes, overweight status, prior heart attacks, and family history of the condition.

During AFib Awareness Month in September, the American Heart Association is emphasizing that AFib is manageable and treatable with proper medical care. Treatment options include medication, procedures, and lifestyle changes such as weight management, increased physical activity, smoking cessation, and blood pressure control. Patients and caregivers can find support through the Association's online community at MyAFibExperience.org and access additional resources at Heart.org/AFib.

The research was sponsored by the American Stroke Association, a division of the American Heart Association, with funding support from the HCA Healthcare Foundation, which also serves as a national sponsor of the Together to End Stroke initiative and AFib Awareness Month. The findings underscore the critical importance of regular health conversations with healthcare professionals and increased public awareness to address this growing public health concern.

Curated from NewMediaWire

blockchain registration record for this content
FisherVista

FisherVista

@fishervista